drugset / Trial / NCT00004381
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Phase 2
Completed
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Rockefeller University · collab
Treatment
Summary
OBJECTIVES: I. Compare the efficacy of preventive vs. therapeutic tin mesoporphyrin in direct Coombs' test-positive ABO hemolytic disease of the newborn and glucose-6-phosphate dehydrogenase deficiency in infants living in Greece. II. Assess the safety of tin mesoporphyrin in high-risk newborns.
Timeline
- Start
- 1999-12
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | stannsoporfin | Small molecule | — | — |